Reolysin
1 clinical trial
1 abstract
1 indication
Indication
Breast CancerAbstract
Mechanisms of mammalian orthoreovirus-induced cell death and NF-kB activation in ER+ breast cancer.Org: Iowa State University,
Clinical trial
A Randomized Phase II Study of Reolysin For Patients Receiving Standard Weekly Paclitaxel Therapy as Therapy For Advanced/Metastatic Breast CancerStatus: Completed, Estimated PCD: 2016-11-18